TNFSF10 and renal carcinoma: As shown in Figs. 7a, b, we found that combined treatment with BIX and TRAIL increased apoptosis and PARP cleavage in renal carcinoma cells (ACHN and A498), breast carcinoma cells (MCF-7), and human lung carcinoma cells (A549).